Abstract |
In vivo administration of cobra factor (CoF) the C3-activating protein of cobra venom, had no suppressive effect on the in vitro response of lymphocytes to PHA, LPS or allogeneic cells; nor did it affect the generation of cells cytotoxic to allogeneic target cells. HVG reactivity was inhibited by commercially available but not purified CoF, and the latter also failed to prolong skin allograft survival. It is concluded that in vivo complement depletion does not interfere with T cell responses, and that previous reports of prolonged survival of skin allografts and inhibition of cutaneous delayed hypersensitivity reactions following treatment with CoF may have been due to impurities in the preparations used.
|
Authors | V M Rumjanek, L Brent, M B Pepys |
Journal | Immunology
(Immunology)
Vol. 34
Issue 6
Pg. 1117-23
(Jun 1978)
ISSN: 0019-2805 [Print] England |
PMID | 355121
(Publication Type: Journal Article)
|
Chemical References |
- Elapid Venoms
- Complement System Proteins
|
Topics |
- Animals
- Complement System Proteins
- Elapid Venoms
(pharmacology)
- Female
- Graft Survival
- Host vs Graft Reaction
- Immunity, Cellular
- Lymphocyte Activation
- Male
- Mice
- Skin Transplantation
- T-Lymphocytes
(immunology)
- Transplantation, Homologous
|